Dynamics of injected somatostatin in blood of patients with hepatic failure and acromegaly

Abba J. Kastin, Akira Arimura, David Gonzalez-Barcena, James Fishback, Andrew V Schally, David H. Coy

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Plasma somatostatin levels were measured by radioimmunoassay (RIA) at various times after rapid injection into the blood of 4 patients with acromegaly, 4 patients with hepatic failure, and 4 healthy subjects. In contrast to the single peak found in normal and acromegalic individuals, two distinct peaks were observed in each patient with liver failure. The first occurred at about the same time as that observed in the other two groups, but the second occurred about 3 min later. This second peak could not be distinguished immunologically from the intact somatostatin tetradecapeptide. The half-time disappearance of somatostatin in patients with hepatic failure was significantly longer than in the normal subjects. Acromegalic subjects tended to have the shortest half-time disappearance of the injected somatostatin and the highest peak level. The results are consistent with the possibility that altered metabolism and/or binding of somatostatin occurs in hepatic failure and in acromegaly.

Original languageEnglish
Pages (from-to)257-259
Number of pages3
JournalPeptides
Volume1
Issue number3
DOIs
StatePublished - Jan 1 1980
Externally publishedYes

Fingerprint

Acromegaly
Liver Failure
Somatostatin
Blood
Metabolism
Liver
Radioimmunoassay
Healthy Volunteers
Plasmas
Injections

Keywords

  • Acromegaly
  • Half-life
  • Hepatic failure
  • Radioimmunoassay
  • Somatostatin

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

Dynamics of injected somatostatin in blood of patients with hepatic failure and acromegaly. / Kastin, Abba J.; Arimura, Akira; Gonzalez-Barcena, David; Fishback, James; Schally, Andrew V; Coy, David H.

In: Peptides, Vol. 1, No. 3, 01.01.1980, p. 257-259.

Research output: Contribution to journalArticle

Kastin, AJ, Arimura, A, Gonzalez-Barcena, D, Fishback, J, Schally, AV & Coy, DH 1980, 'Dynamics of injected somatostatin in blood of patients with hepatic failure and acromegaly', Peptides, vol. 1, no. 3, pp. 257-259. https://doi.org/10.1016/0196-9781(80)90063-7
Kastin, Abba J. ; Arimura, Akira ; Gonzalez-Barcena, David ; Fishback, James ; Schally, Andrew V ; Coy, David H. / Dynamics of injected somatostatin in blood of patients with hepatic failure and acromegaly. In: Peptides. 1980 ; Vol. 1, No. 3. pp. 257-259.
@article{d06835e78dbb4b7ca08d272e746be805,
title = "Dynamics of injected somatostatin in blood of patients with hepatic failure and acromegaly",
abstract = "Plasma somatostatin levels were measured by radioimmunoassay (RIA) at various times after rapid injection into the blood of 4 patients with acromegaly, 4 patients with hepatic failure, and 4 healthy subjects. In contrast to the single peak found in normal and acromegalic individuals, two distinct peaks were observed in each patient with liver failure. The first occurred at about the same time as that observed in the other two groups, but the second occurred about 3 min later. This second peak could not be distinguished immunologically from the intact somatostatin tetradecapeptide. The half-time disappearance of somatostatin in patients with hepatic failure was significantly longer than in the normal subjects. Acromegalic subjects tended to have the shortest half-time disappearance of the injected somatostatin and the highest peak level. The results are consistent with the possibility that altered metabolism and/or binding of somatostatin occurs in hepatic failure and in acromegaly.",
keywords = "Acromegaly, Half-life, Hepatic failure, Radioimmunoassay, Somatostatin",
author = "Kastin, {Abba J.} and Akira Arimura and David Gonzalez-Barcena and James Fishback and Schally, {Andrew V} and Coy, {David H.}",
year = "1980",
month = "1",
day = "1",
doi = "10.1016/0196-9781(80)90063-7",
language = "English",
volume = "1",
pages = "257--259",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Dynamics of injected somatostatin in blood of patients with hepatic failure and acromegaly

AU - Kastin, Abba J.

AU - Arimura, Akira

AU - Gonzalez-Barcena, David

AU - Fishback, James

AU - Schally, Andrew V

AU - Coy, David H.

PY - 1980/1/1

Y1 - 1980/1/1

N2 - Plasma somatostatin levels were measured by radioimmunoassay (RIA) at various times after rapid injection into the blood of 4 patients with acromegaly, 4 patients with hepatic failure, and 4 healthy subjects. In contrast to the single peak found in normal and acromegalic individuals, two distinct peaks were observed in each patient with liver failure. The first occurred at about the same time as that observed in the other two groups, but the second occurred about 3 min later. This second peak could not be distinguished immunologically from the intact somatostatin tetradecapeptide. The half-time disappearance of somatostatin in patients with hepatic failure was significantly longer than in the normal subjects. Acromegalic subjects tended to have the shortest half-time disappearance of the injected somatostatin and the highest peak level. The results are consistent with the possibility that altered metabolism and/or binding of somatostatin occurs in hepatic failure and in acromegaly.

AB - Plasma somatostatin levels were measured by radioimmunoassay (RIA) at various times after rapid injection into the blood of 4 patients with acromegaly, 4 patients with hepatic failure, and 4 healthy subjects. In contrast to the single peak found in normal and acromegalic individuals, two distinct peaks were observed in each patient with liver failure. The first occurred at about the same time as that observed in the other two groups, but the second occurred about 3 min later. This second peak could not be distinguished immunologically from the intact somatostatin tetradecapeptide. The half-time disappearance of somatostatin in patients with hepatic failure was significantly longer than in the normal subjects. Acromegalic subjects tended to have the shortest half-time disappearance of the injected somatostatin and the highest peak level. The results are consistent with the possibility that altered metabolism and/or binding of somatostatin occurs in hepatic failure and in acromegaly.

KW - Acromegaly

KW - Half-life

KW - Hepatic failure

KW - Radioimmunoassay

KW - Somatostatin

UR - http://www.scopus.com/inward/record.url?scp=0019191628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019191628&partnerID=8YFLogxK

U2 - 10.1016/0196-9781(80)90063-7

DO - 10.1016/0196-9781(80)90063-7

M3 - Article

VL - 1

SP - 257

EP - 259

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 3

ER -